City
Epaper

Russian envoy Nikolay Kudashev expresses happiness over COVID-19 vaccine Sputnik V rollout in India

By ANI | Updated: May 15, 2021 19:45 IST

Russian Ambassador to India, Nikolay Kudashev on Saturday expressed his happiness over the rollout of COVID-19 vaccine Sputnik V in India.

Open in App

Russian Ambassador to India, Nikolay Kudashev on Saturday expressed his happiness over the rollout of COVID-19 vaccine Sputnik V in India.

"Happy that the day, when @sputnikvaccine had rolled out in India, has come. Hope it will help our countries to cope with the global threat of #COVID19 following our special and privileged strategic partnership as well as fair and equal approach to international cooperation. Congratulations!" tweeted Kudashev.

Sputnik V has become the first foreign-made vaccine to be used in India contributing to the world's largest COVID-19 vaccination campaign.

Inoculations with Sputnik V in Hyderabad started Friday followed the arrival of the first batch of the vaccine in India on May 1, 2021. The second batch of Sputnik V is expected to arrive in India by the end of the week.

With the Sputnik V COVID-19 vaccine receiving clearance in India, Deepak Sapra, Global Head of Custom Pharma Services at Dr Reddy's Laboratories received the first jab of the vaccine in Hyderabad on Friday.

Sputnik V was approved for use in India on April 12, 2021 and granted an emergency use authorisation. India is the leading production hub for Sputnik V.

To date Sputnik V is registered in 65 countries with total population of over 3.2 billion people. Post-vaccination studies in a number of countries demonstrated that Sputnik V is the safest and most effective vaccine against coronavirus. Sputnik V ranks second among coronavirus vaccines globally in terms of the number of approvals issued by government regulators.

The imported doses of the Sputnik V COVID-19 vaccine are presently priced at Rs 948 (+5 per cent GST) per dose, with the possibility of a lower price point when local supply begins.

Efficacy of Sputnik V is 97.6 per cent based on the analysis of data on the coronavirus infection rate among those in Russia vaccinated with both components of Sputnik V from December 5, 2020 to March 31, 2021.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Global head of custom pharma servicesindiaHyderabadNagarHyderIndiUk-indiaRepublic of indiaSputnik vIndia indiaSputnik v. rdif
Open in App

Related Stories

NationalDonald Trump Imposes Additional 25% Tariff on India, Total Tariff Now 50%

TechnologyWill the Government Have to Offer More Incentives on EVs? NITI Aayog Raises Concerns Over Slow Sales Growth

OpinionsWhy is Trump So Upset with India?

MumbaiUniversity of Bristol Chooses Mumbai for Its First Overseas Campus, Set to Open in September 2026

NationalRaksha Bandhan 2025: Now You Can Send a Rakhi to Your Brother in India Post's Waterproof Envelope — Here's How to Track Your Parcel

International Realted Stories

International"Don't want to get to a point where we hurt ourselves," White House on 50pc tariffs on India, China

InternationalGhanaian ministers among 8 killed in helicopter crash

InternationalUCLA says Trump administration suspends $584 mln federal grants

InternationalTwo dead, 5 missing after landslide in China's Guangzhou

InternationalTech glitch grounds United Airlines flights, sparks delays across major US airports